Showing 9331-9340 of 23030 results for "".
Can a CME Course Help the Disruptive Physician?
https://reachmd.com/programs/clinicians-roundtable/can-a-cme-course-help-the-disruptive-physician/3289/Disruptive Physicians: Do you work with one? Do you manage one? What can you do to help a disruptive or "distracted" physician? Our guest Dr. Charles Samenow, instructor in the Department of Psychiatry and Behavioral Sciences at the George Washington University School of Medicine and Health ScienEducating Nurse Practitioners on Perinatal Mental Health
https://reachmd.com/programs/advances-in-womens-health/educating-nurse-practitioners-on-perinatal-mental-health/16172/How can nurse practitioners be better equipped to serve pregnant and postpartum patients experiencing perinatal mental health disorders?Improving Diabetes Care with Technology: A Look at Continuous Glucose Monitors
https://reachmd.com/programs/diabetes-discourse/improving-diabetes-care-with-technology-a-look-at-continuous-glucose-monitors/12252/How is technology like continuous glucose monitors impacting the way we care for patients with diabetes?Finding Gratitude in the Times of Pandemic
https://reachmd.com/programs/covid-19-frontlines/finding-gratitude-in-the-times-of-pandemic/11365/A small token of gratitude can go a long way in the middle of a pandemic, as dermatologist Dr. Michael Greenberg experienced firsthand.Decline Reported in Prevalence of Dementia in the U.S.
https://reachmd.com/programs/the-jama-report/decline-reported-prevalence-dementia-us/8422/A new study in JAMA reported a decline in the prevalence of dementia in the United States between 2000 and 2012.Bioidentical vs Synthetic Hormone Therapy for Menopausal Women: Which Option is Safer?
https://reachmd.com/programs/clinicians-roundtable/bioidentical-synthetic-hormone-therapy-menopausal-women-which-option-safer/7918/Dr. Jocelyn Slaughter-Moore discusses bioidentical and synthetic hormone therapies, and how their respective safety and efficacy profiles compare.Innovations in Diagnosis and Treatment of Multiple Sclerosis
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/innovations-diagnosis-treatment-multiple-sclerosis/8215/New innovations are helping doctors establish earlier diagnoses and start more targeted treatments for MS patients.A Different Kind of Safe Sex: Fragility Fractures and Effects on Intimacy and Sexuality
https://reachmd.com/programs/sexmed/different-kind-safe-sex-fragility-fractures-effects-intimacy-sexuality/7904/Host Dr. Michael Krychman welcomes Dr. Risa Kagan to discuss the intimacy and sexuality issues that patients face when they are dealing with fragility fractures. Dr. Kagan is Clinical Professor of Obstetrics, Gynecology, and Reproductive Sciences at the University of California, San Francisco. SinceUncovering Barriers to HCC Surveillance in Patients with Cirrhosis
https://reachmd.com/programs/project-oncology/uncovering-barriers-to-hcc-surveillance-in-patients-with-cirrhosis/24332/Dive into the findings from a recent study that focused on gaps and barriers to hepatocellular carcinoma surveillance in patients with cirrhosis.Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
https://reachmd.com/programs/neurofrontiers/multiplex-proteomic-biomarkers-ms/54239/Multiplex proteomic biomarker panels are redefining how we understand and monitor multiple sclerosis (MS) by capturing interconnected pathways in a single sample. Hear from Dr. Raphael Schneider as he explores how these tools could inform prognosis, risk stratification, and clinical trial design, wh